New Vircell COVID-19 Serology Assays
Products are for professional/laboratory use only. Abacus dx is pleased to announce the launch of two new ELISA kits for the diagnosis of COVID-19 as well as two monotest kits for VirClia systems.
Serology allows confirmation of infection in symptomatic and asymptomatic patients.
Reference | Description | Kit Contents | Insert Sheet |
G1032 | COVID-19 ELISA IgG | 96 tests | View here > |
MA1032 | COVID-19 ELISA IgM+IgA | 96 tests | View here > |
VCM097 | COVID-19 VIRCLIA IgG MONOTEST | 24 tests | View here > |
VCM098 | COVID-19 VIRCLIA IgM+IgA MONOTEST | 24 tests | View here > |
Main features of Vircell COVID-19 serology assays
- The use of SARS-CoV-2 recombinant antigens improves the performance of the kits.
- IgM + IgA detection complements molecular tests when the viral load decreases or when false negatives are suspected due to unsuitable samples in patients with clear symptoms.
- The combination of IgM + IgA significantly improves sensitivity since COVID-19 affects the mucous membrane. The early production of IgA antibodies in this kind of infections could be particularly high.
- IgG detection allows monitoring and confirming recovery and possible immunity, when other molecular and serological markers become negative.
Please check regulatory status in your country.
function resizeCTA(){
jQuery(".em_ctab__cta_main_container").each(function(){
var containerHeight = jQuery(this).outerHeight(); var containerWidth = jQuery(this).width();
var content = jQuery(this).find('.em_ctab__cta_content p'); var button = jQuery(this).find('.em_ctab__cta_button');
button.css('top', (containerHeight/2 - button.outerHeight()/2) );
var marginRight = button.outerWidth() + 25;
content.css('margin-right', marginRight);
});
}
jQuery( window ).resize(function() { resizeCTA(); });
jQuery(document).ready(function(){ resizeCTA(); });